Letters to the Editor

A rescue approach in refractory diffuse large B-cell lymphoma with obinutuzumab-redirected cytokine-induced killer cells: a first-in-human case report

Hematology, San Bortolo Hospital, Vicenza
Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy; Veneto Institute of Oncology-IOV IRCCS, Padua
Veneto Institute of Oncology-IOV IRCCS, Padua
Hematology, San Bortolo Hospital, Vicenza
Hematology, San Bortolo Hospital, Vicenza
Advanced Cellular Therapy Laboratory, Hematology, San Bortolo Hospital, Vicenza
Advanced Cellular Therapy Laboratory, Hematology, San Bortolo Hospital, Vicenza
Advanced Cellular Therapy Laboratory, Hematology, San Bortolo Hospital, Vicenza
Advanced Cellular Therapy Laboratory, Hematology, San Bortolo Hospital, Vicenza
Advanced Cellular Therapy Laboratory, Hematology, San Bortolo Hospital, Vicenza
Hematology, San Bortolo Hospital, Vicenza
Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua
Hematology and Bone Marrow Transplant Unit, Section of Biomedicine of Innovation, Department of Engineering for Innovative Medicine, University of Verona, Verona
Hematology and Bone Marrow Transplant Unit, Section of Biomedicine of Innovation, Department of Engineering for Innovative Medicine, University of Verona, Verona
Hematology Unit, Department of medicine, University of Padua, Padua
Hematology Unit, Department of medicine, University of Padua, Padua
Hematology, San Bortolo Hospital, Vicenza
Advanced Cellular Therapy Laboratory, Hematology, San Bortolo Hospital, Vicenza
Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy; Veneto Institute of Oncology-IOV IRCCS, Padua
Haematologica Early view May 9, 2024 https://doi.org/10.3324/haematol.2023.284881